Association of PARP1 polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma

The genetic aetiology and the molecular mechanisms that characterize high‐risk neuroblastoma are still little understood. The majority of high‐risk neuroblastoma patients do not take advantage of current induction therapy. So far, one of the main reasons liable for cancer therapeutic failure is the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Cell Mol Med
Asıl Yazarlar: Avitabile, Marianna, Lasorsa, Vito Alessandro, Cantalupo, Sueva, Cardinale, Antonella, Cimmino, Flora, Montella, Annalaura, Capasso, Dalila, Haupt, Riccardo, Amoroso, Loredana, Garaventa, Alberto, Quattrone, Alessandro, Corrias, Maria Valeria, Iolascon, Achille, Capasso, Mario
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7171401/
https://ncbi.nlm.nih.gov/pubmed/32103589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15058
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller